Rachael Lester
Vermögen: - $ am 30.06.2026
Vermögen: - $ am 30.06.2026
Rachael Lester is currently Chief Business Officer & Senior VP at CytomX Therapeutics, Inc. Formerly, Ms. Lester was SVP-Business Development & Corporate Strategy at Harpoon Therapeutics, Inc. and Chief Business Officer at Replicate Bioscience, Inc. Education includes an undergraduate degree from the University of Pennsylvania and an MBA from Kellogg School of Management.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 20.04.2026 | 0 ( -.--% ) | - $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| CYTOMX THERAPEUTICS, INC. | Corporate Officer/Principal | 20.10.2025 |
| Unternehmen | Position | Ende |
|---|---|---|
Replicate Bioscience, Inc.
Replicate Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in developing of replicate srRNA vectors deliver to cells in the body an instruction manual for making a therapeutic protein | Corporate Officer/Principal | - |
| HARPOON THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kellogg School of Management
Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CytomX Therapeutics, Inc.
CytomX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer | Health Technology |
Harpoon Therapeutics, Inc.
Harpoon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immunotherapy company that develops T-cell engagers to treat cancer and other diseases | Health Technology |
Replicate Bioscience, Inc.
Replicate Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in developing of replicate srRNA vectors deliver to cells in the body an instruction manual for making a therapeutic protein | Commercial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen